tiprankstipranks
Advertisement
Advertisement
Chemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data
PremiumCompany AnnouncementsChemomab Sets Single-Phase 3 Path With FDA After Strong 2025 Nebokitug Data
2M ago
Chemomab Therapeutics sees cash runway through 1Q27
Premium
The Fly
Chemomab Therapeutics sees cash runway through 1Q27
2M ago
Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year
Premium
The Fly
Chemomab Therapeutics reports FY25 EPS (1c) vs. (4c) last year
2M ago
Chemomab announces presentations at AASLD 2025 on nebokitug data
PremiumThe FlyChemomab announces presentations at AASLD 2025 on nebokitug data
7M ago
CMMB Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CMMB Earnings this Week: How Will it Perform?
7M ago
Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug
Premium
Company Announcements
Chemomab Therapeutics Advances Phase 3 Plans for Nebokitug
9M ago
Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
PremiumCompany AnnouncementsChemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
9M ago
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
Premium
Ratings
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
9M ago
Chemomab Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Chemomab Therapeutics Reports Q2 2025 Financial Results
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100